Private Trust Company’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6K | Buy |
260
+160
| +160% | +$7.78K | ﹤0.01% | 1733 |
|
|
2025
Q1 | $3.4K | Hold |
100
| – | – | ﹤0.01% | 2160 |
|
|
2024
Q4 | $3.94K | Sell |
100
-5,151
| -98% | -$203K | ﹤0.01% | 2063 |
|
|
2024
Q3 | $247K | Buy |
5,251
+47
| +0.9% | +$2.21K | 0.02% | 622 |
|
|
2024
Q2 | $281K | Hold |
5,204
| – | – | 0.03% | 545 |
|
|
2024
Q1 | $355K | Hold |
5,204
| – | – | 0.04% | 460 |
|
|
2023
Q4 | $326K | Buy |
5,204
+2,000
| +62% | +$125K | 0.04% | 461 |
|
|
2023
Q3 | $145K | Hold |
3,204
| – | – | 0.02% | 669 |
|
|
2023
Q2 | $180K | Buy |
3,204
+1,104
| +53% | +$62K | 0.02% | 600 |
|
|
2023
Q1 | $95K | Sell |
2,100
-2,000
| -49% | -$90.5K | 0.01% | 791 |
|
|
2022
Q4 | $167K | Buy |
4,100
+950
| +30% | +$38.7K | 0.02% | 568 |
|
|
2022
Q3 | $206K | Buy |
3,150
+3,000
| +2,000% | +$196K | 0.03% | 471 |
|
|
2022
Q2 | $9K | Buy |
+150
| New | +$9K | ﹤0.01% | 1530 |
|